Nordal KP, Halse J, Kronborg J, Dahl E, Hartmann A
Nasal calcitonin reduces bone loss in renal transplant recipients
Am Soc Nephrol
J Am Soc Nephrol (abstract) (Nov) 6:1109 1995

Using the newly available nasal spray form of calcitonin these authors demonstrate a reduction in bone loss after transplant. This study is, to my knowledge, the first successful intervention trial in transplant related bone disease. After one year a suggestion of reduced fracture rate was also noted, but the trial needs to be continued and expanded. (Sherrard)

To go back use the BACK button on your browser.
Otherwise click on the desired link to this article below:
Am Soc Nephrol
CRF by problem area : Bone disease/aluminum

---

---